Cancer Research ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏ ͏
| | | | What data do we already have that can help us understand less heard voices in research and publishing? How many publications contain fabricated, falsified, or plagiarised data, and how should we deal with fake studies?
The latest in our Research with Integrity series sees Andrew Porter, Research Integrity and Training Adviser at our Manchester Institute, and the wider research integrity team give us the low-down of research integrity from the 8th World Conference on Research Integrity.
Read along to find out what they think you should know about this culture change journey. |
| | |
| | |
|
|
|
|
Funding & Research Opportunities |
| Get in touch with our office for confidential advice on eligibility, remit and funding options prior to applying. |
|
| | | | | | | | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
| | | | | | Applications accepted all year round |
|
|---|
|
| | |
|
|
Announcing the June winner of our #ResearchisBeautiful image campaign |
| Congratulations to Michaela Macdonald from Carcinotech for winning the image of the month in our Research is Beautiful image campaign.
Michaela’s image captures a 3D-bioprinted living tumour derived from donor glioblastoma tissue. Carcinotech specialises in crafting these bioengineered tumours from patient biopsies, offering researchers and drug developers an alternative to animal models for screening and testing cancer therapies.
Interested in taking part? Drop us an email by 25th of each month with your wonderful moments of science to win our monthly pick. T&Cs apply. |
| | |
|
|
|
| | | | | Calling all researchers drafting a manuscript for publication that includes in vitro models.
You are invited to take part in user testing for new minimum reporting standards. RIVER (Reporting In Vitro Experiments Responsibly) is a set of six recommendations helping to ensure that manuscripts include the information necessary for a reader to assess the methodological rigour and reliability of the study.
Submit your draft manuscript to receive expert feedback from members of the RIVER working group, improve the transparency of your work and its chance of successful publication. | | |
| | | | | | | We’re jointly funding additional awards in the NC3Rs Partnership and Impact scheme for researchers seeking to achieve a 3Rs impact within cancer research.
These awards support researchers to work together to test and share 3Rs approaches across labs, accelerating uptake and achieving wider 3Rs impacts.
Applications can include studies to build the evidence base for a 3Rs approach, demonstrate transferability, or apply a model to a new discipline. We also encourage applications for studies demonstrating that an approach is fit-for-purpose in a new lab or organisation in order to build further confidence in the model’s use.
You can watch the launch webinar now and register for the next webinar on 9 July about writing a competitive application. | | |
|
|---|
|
|
|
|
Join our research data community |
| Get involved with one of our six researcher-led communities tackling common challenges in research data to share best practices and drive data culture change.
Our communities focus on the special interests of health systems data, spatial biology data, data and samples reuse, public involvement and diversity, data and compute infrastructure and training and careers.
You’ll help guide our delivery of services and solutions, enabling researchers to take data-intensive approaches in their work. |
| | |
|
|
|
| | | | | Bissan Al-Lazikani (MD Anderson Cancer Center) will be chairing a session on AI and machine learning focused on how these cutting-edge technologies are shaping brain tumour diagnosis, treatment and patient care.
Join Steven Niederer (Imperial College London/The Alan Turing Institute) and Richard Gilbertson (Cancer Research UK Cambridge Institute), as they delve into the applications of AI in overcoming challenges in drug discovery and development. Steven will share insights and lessons from his work on creating a virtual heart.
Secure a discounted ticket now to join the conversation and follow #CRUKBrain24 on our social channels for more updates. | | |
| | | | | | | Are you interested in showcasing your work to the precision oncology and translational research community?
Don’t miss the opportunity to present a poster or give a talk alongside international experts, sharing insights and exploring cutting-edge technologies in the field. Your abstract will also be published in the ESMO open-access journey, reaching the wider research community.
The abstract submission deadline is 23 July. | | |
|
|---|
|
|
|
|
What did you think of this email? |
|
| | |
|
|
| | Together we are
beating cancer |
| | |
|---|
|
|
|
| | | You are playing a crucial role in helping us beat cancer sooner, so we'd like to continue to keep you updated on what we're up to. You can manage your preferences and unsubscribe here.
Your details are safe with us. Check out our Privacy Policy.
Our supporters are at the heart of everything we achieve at Cancer Research UK. Read our Fundraising Promise.
This email is from Cancer Research UK. Cancer Research UK is a registered charity in England and Wales (1089464), Scotland (SC041666), the Isle of Man (1103) and Jersey (247). A company limited by guarantee. Registered company in England and Wales (4325234) and the Isle of Man (5713F). Registered address: 2 Redman Place, London, E20 1JQ. |
|
|
|
